Pacer Advisors’s Albireo Pharma Inc ALBO Stock Holding History

Pacer Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,151	Closed	-$41K	–	1590
2021 Q1	$41K	Buy	1,151 +82	+8%	+$3.03K	﹤0.01%	1464
2020 Q4	$40K	Buy	+1,069	New	+$38.9K	﹤0.01%	1437

Other funds holding ALBO

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Pacer Advisors's ALBO Position: Q2 2021 in Review

Pacer Advisors sold out of Albireo Pharma Inc (ALBO) in Q2 2021, closing a stake of 1,151 shares — an estimated $41K sold.

Pacer Advisors first reported a position in ALBO in Q4 2020 and held it in 2 quarters. The position peaked at $41K in Q1 2021. 99 funds tracked by Wall St. Rank hold ALBO as of Q2 2021.

Pacer Advisors reported no remaining Albireo Pharma Inc position as of Q2 2021 after selling out during the quarter.
Pacer Advisors sold 1,151 Albireo Pharma Inc shares in Q2 2021, an estimated $41K.
Pacer Advisors first reported a position in Albireo Pharma Inc in Q4 2020 and held it in 2 quarters.
Pacer Advisors's Albireo Pharma Inc position peaked at $41K in Q1 2021.
99 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.